2bni: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2bni.gif|left|200px]] | [[Image:2bni.gif|left|200px]] | ||
'''PLI MUTANT E20C L16G Y17H, ANTIPARALLEL''' | {{Structure | ||
|PDB= 2bni |SIZE=350|CAPTION= <scene name='initialview01'>2bni</scene>, resolution 1.50Å | |||
|SITE= | |||
|LIGAND= | |||
|ACTIVITY= | |||
|GENE= | |||
}} | |||
'''PLI MUTANT E20C L16G Y17H, ANTIPARALLEL''' | |||
==Overview== | ==Overview== | ||
Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
2BNI is a [ | 2BNI is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BNI OCA]. | ||
==Reference== | ==Reference== | ||
Structure-based engineering of internal cavities in coiled-coil peptides., Yadav MK, Redman JE, Leman LJ, Alvarez-Gutierrez JM, Zhang Y, Stout CD, Ghadiri MR, Biochemistry. 2005 Jul 19;44(28):9723-32. PMID:[http:// | Structure-based engineering of internal cavities in coiled-coil peptides., Yadav MK, Redman JE, Leman LJ, Alvarez-Gutierrez JM, Zhang Y, Stout CD, Ghadiri MR, Biochemistry. 2005 Jul 19;44(28):9723-32. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16008357 16008357] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Ghadiri, M R.]] | [[Category: Ghadiri, M R.]] | ||
Line 18: | Line 27: | ||
[[Category: antiparallel four helix bundle acyl transferase]] | [[Category: antiparallel four helix bundle acyl transferase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 16:04:13 2008'' |
Revision as of 17:04, 20 March 2008
| |||||||
, resolution 1.50Å | |||||||
---|---|---|---|---|---|---|---|
Coordinates: | save as pdb, mmCIF, xml |
PLI MUTANT E20C L16G Y17H, ANTIPARALLEL
OverviewOverview
Cavities and clefts are frequently important sites of interaction between natural enzymes or receptors and their corresponding substrate or ligand molecules and exemplify the types of molecular surfaces that would facilitate engineering of artificial catalysts and receptors. Even so, structural characterizations of designed cavities are rare. To address this issue, we performed a systematic study of the structural effects of single-amino acid substitutions within the hydrophobic cores of tetrameric coiled-coil peptides. Peptides containing single glycine, serine, alanine, or threonine amino acid substitutions at the buried L9, L16, L23, and I26 hydrophobic core positions of a GCN4-based sequence were synthesized and studied by solution-phase and crystallographic techniques. All peptides adopt the expected tetrameric state and contain tunnels or internal cavities ranging in size from 80 to 370 A(3). Two closely related sequences containing an L16G substitution, one of which adopts an antiparallel configuration and one of which adopts a parallel configuration, illustrate that cavities of different volumes and shapes can be engineered from identical core substitutions. Finally, we demonstrate that two of the peptides (L9G and L9A) bind the small molecule iodobenzene when present during crystallization, leaving the general peptide quaternary structure intact but altering the local peptide conformation and certain superhelical parameters. These high-resolution descriptions of varied molecular surfaces within solvent-occluded internal cavities illustrate the breadth of design space available in even closely related peptides and offer valuable models for the engineering of de novo helical proteins.
About this StructureAbout this Structure
2BNI is a Single protein structure of sequence from [1]. Full crystallographic information is available from OCA.
ReferenceReference
Structure-based engineering of internal cavities in coiled-coil peptides., Yadav MK, Redman JE, Leman LJ, Alvarez-Gutierrez JM, Zhang Y, Stout CD, Ghadiri MR, Biochemistry. 2005 Jul 19;44(28):9723-32. PMID:16008357
Page seeded by OCA on Thu Mar 20 16:04:13 2008